Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically defined stable population

American Journal of Cardiology

Volumn 78, Issue 12, 1996, Pages 1345-1349

  Le Feuvre, Catherine A ^a   Connolly, Stuart J ^a,b   Cairns, John A ^a   Gent, Michael ^a   Roberts, Robin S ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; CANADA; COMPARATIVE STUDY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE;

AGE FACTORS; AGED; HOSPITAL MORTALITY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; ONTARIO; PROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 0030589340     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00652-2     Document Type: Article

References (28)

1. Sobel B. Coronary thrombolysis and the new biology. J Am Coll Cardiol 1989;14:850-860.
2. MacMillan RL, Brown KWG. Comparison of the effects of treatment of acute myocardial infarction in a coronary care unit and on a general medical ward. Can Med Assoc J 1975;105:1037-1040.
3. Hofvendalil S. Influence of treatment in a coronary care unit of prognosis in acute myocardial infarction. Acta Med Scand 1971;519(suppl 1):1-78.
4. Christianson I, Iverson K, Skouby AP. Benefits obtained by the introduction of a coronary care unit. Acta Med Scand 1971;189:285-291.
5. Theroux P, Ziden RM. Unstable angina: pathogenesis, diagnosis and treatment. Curr Probl Cardiol 1993;13:159-231.
6. ISIS-1 (First International Study of Infart Survival) Collaborative Group. Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2:57-66.
7. Yusuf S, Peto R, Lewis J, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;17:335-371.
8. ISIS-2 Collaborative Group. Randomized trial of IV streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;2:349-360.
9. Gruppo Italiano per Lo studio della streptochinasi nell 'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
10. Wilcox RG, Von der Luppe G. Olsson CG, Jensen G, Skene AM, Hamptom Jr. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of early thrombolysis (ASSET). Lancet 1988;2:525-530.
11. Aims Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction. Preliminary report of a placebo-controlled clinical trial. Lancet 1988;2:545-549.
12. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results for all randomized trials of more than 100 patients. Lancet 1994;343:311-322.
13. The Gusto Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
14. ISIS-3: A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 1992;339:753-770.
15. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomized factorial trial assessing early captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
16. Cairns JA, Singer J, Gent M, Holder DA, Rogers D, Sackett DL, Sealey BJ, Tanser PH, Vandervoort M. Coronary care unit utilization in Hamilton, Ontario, a city of 375,000 people. Can J Cardiol 1988;4(1):25-32.
17. Cairns JA, Singer J, Gent M, Holder DA, Rogers D, Sackett DL, Sealey BJ, Tanser PH, Vandervoort M. One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 people. Can J Cardiol 1989;5(5):239-246.
18. GISSI. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of GISSI Study. Lancet 1987;2:871-874.
19. Goldberg R, Govak E, Yarezebski J, Hosmer DE, Dalen P, Gore JM, Alpert JS, Dalen JE. A community wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-1953.
20. Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, Sackett DL, Sealey BJ, Tanser PH. Aspirin, sulpinpyrazone or both in unstable angina. Results of a Canadian multi-centre trial. N Engl J Med 1985;313:1369-1375.
21. Cairns JA, Connolly SJ, Gent M, Roberts R. Post-myocardial infarction mortality in patients with ventricular premature depolarizations (Canadian Amiodarone Myocardial Infarction Arrhythmia Trial) pilot study. Circulation 1991;84:550-557.
22. deVreede JJM, Gorgels AMP, Verstraaten GMP, Vermeer F, Dassen WRM, Wellens HJJ. Did prognosis after acute myocardial infarction change during the past 30 years: a meta-analysis. J Am Coll Card 1991;18:698-706.
23. Gomez-Marin O, Folsom AR, Kottke TE, Wu SC, Jacobs DR, Gillum RF, Edlavitch SA, Blackburn H. Improvement in long-term survival among patients hospitalized with acute myocardial infarction, 1970 to 1980. The Minnesota Heart Survey. N Engl J Med 1987;316:1353-1359.
24. Goldberg R, Szklo M, Tonascia J, Kennedy H. Time trends in prognosis of patients with myocardial infarction: a population-based study. Johns Hopkins Med J 1979;144:73-80.
25. Goldberg R, Gorak E, Yarezebski J, Hosmer DW Jr, Dalen P, Gore JM, Alpert JS, Dalen JE. A community wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-1953.
26. McGovern PG, Folsom AR, Sprafka JM, Burke GL, Doliszny KM, Demirovic J, Naylor JD, Blackburn H. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985. The Minnesota Heart Survey. Circulation 1992;85:172-179.
27. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario Experience 1981-1991. J Am Coll Cardiol 1994;24:1431-1438.
28. Dellborg M, Eriksson P, Rihal M, Swedberg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J 1994;15:5-9.